A new pyridine derivative, 5-(2'-hydroxypropyl)pyridin-3-ol (1), with seven known alkaloids, 3-hydroxy-5-methyl-5,6-dihydro-7H-cyclopenta[b]pyridin-7one (2), penicillenol A 1 (3), penicillenol A 2 (4), a mixture of quinolactacin A 1 (5a) and quinolactacin A 2 (5b), and a mixture of quinolactacin C 1 (6a) and quinolactacin C 2 (6b), were isolated from the culture broth of a marine-derived fungus Xylariaceae sp. SCSGAF0086. Their structures were elucidated by spectroscopic methods. Compound 2 showed weak antimicrobial activity against Bacillus subtilis, and a mixture of 6a and 6b exhibited strong antifouling activity toward Bugula neritina larval settlement.
Gorgonian surfaces are frequently colonized by diverse fungi. These symbiotic fungi are becoming new sources of various bioactive compounds [1a,c] . Pyridine derivatives are rarely obtained from microorganisms [1d,e] . During the course of our investigation of the secondary metabolites of marine gorgonian-derived fungi, the fungal strain Xylariaceae sp. SCSGAF0086 attracted our attention. Preliminary experiments showed that the culture extract of this strain had antimicrobial and antifouling activities. Further investigation of the chemical constituents of the extract led to the finding of a new pyridine derivative, 5-(2'-hydroxypropyl)pyridin-3-ol (1), together with seven known alkaloids 3-hydroxy-7-methyl-6,7-dihydro-cyclopentapyridine-5-one (2) [1f], penicillenol A 1 (3) [2a], penicillenol A 2 (4) [2a] , a mixture of quinolactacin A 1 (5a) [2b,d] and quinolactacin A 2 (5b) [2b,d] , and a mixture of quinolactacin C 1 (6a) [2c,d] and quinolactacin C 2 (6b) [2c,d] ( Figure 1 ). Compounds 1-6b were tested for their antibacterial and antifouling activity. We report herein the isolation, structure elucidation and bioactivities of 1-6b. Compound 1 has a molecular formula of C 8 H 11 NO 2 , as inferred from the HRESIMS (m/z 154.0858 [M+H] + ). The 1 H NMR spectrum exhibited the presence of one methyl, one methylene, four methines [δ H 7.94 (1H, d, J = 2.5 Hz), 7.00 (1H, dd, J = 1.5, 2.5 Hz), 7.85 (1H, d, J = 1.5 Hz), 3.79 (1H, m)], and two hydroxyl groups (δ H 9.78, 4.06). The 13 C NMR and DEPT spectral data of 1 revealed the presence of eight carbons, including one oxymethine, and five unsaturated aromatic carbons. These data suggested that 1 might be a 3,5-di-substituted pyridine derivative. This suggestion was proved by the HMBC spectrum, which showed correlations of H-6 with C-2/C-4, and the small coupling constants of J H-2/H-4 (2.5 Hz) and J H-4/H-6 (1.5 Hz). Furthermore, HMBC correlations of H-9 with C-7/C-8, 8-OH with C-7/C-8/C-9, H-7 with C-8/C-4/C-5/C-6, H-4 with C-6/C-7, and H-6 with C-2/C-4, suggested a CH 3 -CHOH-CH 2 -group attached to C-5 of the pyridine ring. Thus, 1 was determined as shown and named 5-(2'-hydroxypropyl)pyridin-3-ol. It was obtained as a racemic mixture because its specific rotation was recorded as zero. 
Fermentation and extraction:
The fungal strain was inoculated in PDA liquid medium (containing 20 g/L glucose, 200 g/L potato, and 30 g/L sea salt) in 500 mL shake flasks loaded with 120 mL as seed culture and incubated on a rotary shaker (200 rpm) at 28 o C for 3 days. A scale-up cultivation was carried out under static conditions with 20 L broth inoculated with seed culture at 28 o C for 50 days in 120 x 500 mL conical flasks containing the liquid medium (150 mL/flask) composed of glucose (10 g/L), maltose (20 g/L), mannitol (20 g/L), monosodium glutamate (10 g/L), KH 2 PO 4 (0.5 g/L), MgSO4·7H 2 O (0.3 g/L), corn steep liquor (0.5 g/L), monosodium glutamate (10 g/L), yeast extract (3 g/L), and seawater (adjusted to pH 7.0 before sterilization).
Isolation and purification of compounds:
The fermentation broth (20 L) was extracted with EtOAc. The EtOAc extract was concentrated in vacuo to afford 11.5 g of residue, which was subjected to reversed-phase RP-18 CC, eluting with H 2 O/MeOH (v/v, from 100:0 to 0:100) to yield 11 fractions. Fr.1 isolated from H 2 O/MeOH (80:20) was fractionated on Sephadex LH-20 with MeOH to afford 3 sub-fractions; Fr.1-1 was purified by semipreparative HPLC (sp-HPLC) by elution with MeOH/H 2 O (35:65) to offer 2 (0.7 mg, t R =13 min), and Fr.1-3 was purified by sp-HPLC by elution with MeOH/H 2 O (16:84) to give 1 (1.9 mg, t R = 19 min). Fr.2, isolated from H 2 O/MeOH (65:35), was fractionated on Sephadex LH-20 with MeOH to afford 5 sub-fractions; Fr.2-1 was purified by sp-HPLC by elution with MeOH/H 2 O (36:64) to give a mixture of 5a and 5b (15 mg, t R = 22 min) and a mixture of 6a and 6b (10 mg, t R = 30 min). Fr.5, isolated from H 2 O/MeOH (25:75), was fractionated on silica gel by elution with CHCl 3 /MeOH (10:0-0:10) to offer 8 sub-fractions; Fr.5-3 was purified by sp-HPLC by elution with ACN/H 2 O (40:60) to give 3 (3 mg, t R = 70 min) and 4 (5 mg, t R = 75 min).
Antibacterial bioassays: Antibacterial activities of 1-6b were tested against E. coli and B. subtilis using a standard disc diffusion assay [2e]. Sterile 6 mm diameter circular discs of filter paper were loaded with 50 μg of the test compounds dissolved in methanol, evaporated to dryness, and then placed onto the bacterial lawn. An additional set of discs with 10 μg mL -1 of streptomycin was used as the positive control.
Larval settlements bioassays: Larval settlement bioassays were performed using sterile 24-well polystyrene plates [2f]. In the assay, nearly 20 competent larvae were added to each well in 1 mL of the test solution. Wells containing only fresh sea water with DMSO served as the controls. The plates were incubated at 27°C for 1 h. The percentage of larval settlement was determined by counting the settled and live individuals under a dissecting microscope, and expressing the result as a proportion of the total number of larvae in the well. Compounds were tested at a concentration of 50 μg/mL, and then for the active compound, its IC 50 value was further calculated at concentrations ranging from 1 to 200 μg/mL. (1) 
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